Aston University develops novel bone cancer therapy which has 99% success rate
Aston University in the UK has developed a gallium-doped bioactive glass that kills 99% of bone cancer cells and regenerates diseased bones.
Manuka honey kills human breast cancer cells
Researchers at UCLA in the United States found that Manuka honey targets breast cancer cells in human cell lines and mice, reducing tumour growth by 84% in mice.
Tumor-destroying soundwaves receive FDA approval for liver treatment in humans
The US FDA has approved HistoSonics to market a liver cancer treatment using histotripsy, an ultrasound-based technology developed at the University of Michigan.
Circular RNAs – the new frontier in cancer research
Researchers at Flinders University in Australia are investigating circular RNAs to transform cancer diagnosis and treatment over the next 5-10 years.
Cancer-killing nanobots use hidden weapon
Researchers at Karolinska Institutet in Sweden have developed DNA nanorobots that specifically target and kill cancer cells in mice, showing a 70% reduction in tumour growth.
Glowing dye helps surgeons eradicate prostate cancer
Scientists at the University of Oxford in the UK are using a glowing marker dye to help surgeons remove prostate cancer cells more effectively during surgery, reducing recurrence and side effects.
Chicken feathers to deliver chemotherapy drugs and repair enzymes
Researchers from Kings College London, UK, have developed a new method of drug delivery using proline, an amino acid found in chicken feathers and skin tissue.
Scientists discover blood proteins that may give cancer warning 7 years before diagnosis
Oxford Population Health in the UK has discovered blood proteins that could signal cancer over seven years before diagnosis, potentially revolutionising early detection and prevention.
Breakthrough rice bran nanoparticles show promise as affordable and targeted anticancer agent
Researchers at Tokyo University of Science in Japan are developing nanoparticles from rice bran to target cancer cells more safely and effectively than traditional therapies.
Nanosurgical tool could be key to cancer breakthrough
A groundbreaking study by the University of Leeds has introduced a novel double-barrel nanopipette technology that offers unprecedented insights into how individual cancer cells respond to treatments, potentially revolutionising the development of more effective cancer therapies.